Clinical Trial Update: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating cinacalcet for secondary hyperparathyroidism in haemodialysis patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Penang Hospital, Malaysia | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: UNKNOWN